The biotech-start up BioAmber recently announced that Mitsui, its partner in the Sarnia bio-based succinic acid plant, is investing an additional CDN$25 million (US$19.7 mln) in the joint venture for 10% of the equity, increasing its stake from 30% to 40%.… Login to continue

Login or sign up